2m 2m 2m 2m 2m 2m 2m
Cencora (COR)
NYSE
$280.83+$9.55 (+3.52%)
Price as of Jun 23, 2026 3:56 PM EDT- $52.8BMarket Cap
- -6.76%1-Year Change
- Medical DistributionIndustry
Cencora (COR)
$280.83+$9.55 (+3.52%)
Annual
Quarterly
09/30/2025 | 09/30/2024 | 09/30/2023 | 09/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 321.3B +9.31% | 294.0B +12.12% | 262.2B +9.89% | 238.6B +11.50% | |
Cost of Revenue | 309.9B +9.08% | 284.0B +12.18% | 253.2B +9.95% | 230.3B +11.23% | |
Gross Profit | 11.5B +15.83% | 9.9B +10.61% | 9.0B +7.99% | 8.3B +19.49% | |
Sales and Marketing Expense | 6.5B +14.71% | 5.7B +6.61% | 5.3B +9.51% | 4.8B +34.91% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 501.3M +11.85% | 448.2M +7.01% | 418.8M +7.22% | 390.6M +19.57% | |
Total Operating Expenses | 309.9B +9.08% | 284.0B +12.18% | 253.2B +9.95% | 230.3B +11.23% | |
Operating Profit | 2.6B +20.84% | 2.2B -7.07% | 2.3B -1.08% | 2.4B +0.52% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -291.5M +85.71% | -157.0M -31.42% | -228.9M +8.67% | -210.7M +21.02% | |
Interest Income and Expense and Net | -291.5M +85.71% | -157.0M -31.42% | -228.9M +8.67% | -210.7M +21.02% | |
Total Nonoperating Income and Expense | -78.7M +451.12% | -14.3M -129.13% | 49.0M +79.28% | 27.4M -34.46% | |
Income before Taxes | 2.3B +12.69% | 2.0B -7.26% | 2.2B -1.02% | 2.2B -1.75% | |
Income Taxes | 690.5M +42.46% | 484.7M +13.18% | 428.3M -17.09% | 516.5M -23.73% | |
Extraordinary Items | 837.4M +100.33% | 418.0M N/A | 0 -100.00% | 80.9M +155.17% | |
Net Income | 1.6B +2.99% | 1.5B -13.53% | 1.7B +2.74% | 1.7B +10.32% | |
Net Income from Continuing Operations Applicable to Common | 2.3B +12.69% | 2.0B -7.26% | 2.2B -1.02% | 2.2B -1.75% | |
Basic EPS and Net Income | 8.02 +5.53% | 7.60 -11.83% | 8.62 +5.77% | 8.15 +8.96% | |
Diluted EPS and Net Income | 7.96 +5.71% | 7.53 -11.72% | 8.53 +6.09% | 8.04 +8.80% | |
Basic Weighted Average Shares | 193.8M -2.36% | 198.5M -1.98% | 202.5M -2.86% | 208.5M +1.24% | |
Diluted Weighted Average Shares | 195.2M -2.53% | 200.3M -2.11% | 204.6M -3.13% | 211.2M +1.32% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.4B +39.06% | 3.1B +20.86% | 2.6B -23.50% | 3.4B +33.02% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 4.4B +39.06% | 3.1B +20.86% | 2.6B -23.50% | 3.4B +33.02% | |
Total Current Assets | 52.2B +9.47% | 47.7B +11.49% | 42.8B +8.11% | 39.6B +2.03% | |
Accumulated Depreciation | 3.2B +5.29% | 3.0B +16.50% | 2.6B +15.61% | 2.3B +17.39% | |
Property and Plant and Equipment and Net | 2.5B +16.40% | 2.2B +2.17% | 2.1B +0.008% | 2.1B -1.29% | |
Total Long-Term Assets | 4.2B +14.17% | 3.6B +6.40% | 3.4B +94.03% | 1.8B -1.80% | |
Total Assets | 76.6B +14.14% | 67.1B +7.26% | 62.6B +10.60% | 56.6B -1.36% | |
Income Taxes Payable | 2.0B +1.18% | 1.9B -1.68% | 2.0B +1.44% | 1.9B -1.31% | |
Total Short-Term Debt | 117.8M -79.56% | 576.3M -10.14% | 641.3M -40.09% | 1.1B +256.57% | |
Total Current Liabilities | 57.8B +6.53% | 54.3B +11.15% | 48.8B +12.31% | 43.5B +5.12% | |
Total Long-Term Debt | 7.5B +97.89% | 3.8B -8.06% | 4.1B -10.50% | 4.6B -27.43% | |
Total Long-Term Liabilities | 3.6B +82.57% | 2.0B +5.78% | 1.9B +92.99% | 976.6M -9.80% | |
Total Liabilities | 57.8B +6.53% | 54.3B +11.15% | 48.8B +12.31% | 43.5B +5.12% | |
Retained Earnings | 6.5B +20.62% | 5.4B +25.28% | 4.3B +45.22% | 3.0B +78.25% | |
Total Stockholders Equity | 1.5B +133.46% | 645.9M +23.74% | 522.0M +346.74% | -211.6M -194.72% | |
Total Shares Outstanding | 193.9M -0.52% | 194.9M -2.92% | 200.8M -2.61% | 206.2M -0.91% | |
Cash Flow | |||||
Cash from Operating Activities | 3.9B +11.20% | 3.5B -10.91% | 3.9B +44.70% | 2.7B +1.37% | |
Capital Expenditures | 668.0M +37.11% | 487.2M +6.29% | 458.4M -7.65% | 496.3M +13.26% | |
Cash from Investing Activities | -5.0B +705.26% | -618.1M -76.25% | -2.6B +606.35% | -368.4M -94.00% | |
Dividends Paid | 437.1M +5.03% | 416.2M +4.37% | 398.8M +1.80% | 391.7M +6.83% | |
Cash from Financing Activities | 2.2B +196.49% | -2.3B +4.89% | -2.2B +26.79% | -1.8B -189.76% | |
Financials Ratio | |||||
Gross Margin | 3.57% +5.96% | 3.37% -1.35% | 3.42% -1.72% | 3.48% +7.17% | |
Operating Margin | 0.82% +10.54% | 0.74% -17.11% | 0.89% -9.98% | 0.99% -9.84% | |
Return on Assets | 2.16% -7.07% | 2.33% -20.56% | 2.93% -1.77% | 2.98% -1.58% | |
Return on Equity | 144.31% -44.16% | 258.42% -77.02% | 1,124.39% -96.10% | 28,805.77% +7,540.91% | |
Revenue Growth | 9.31% -23.19% | 12.12% +22.64% | 9.89% -14.00% | 11.50% -9.41% | |
Current Ratio | 0.90 +2.76% | 0.88 +0.31% | 0.88 -3.74% | 0.91 -2.94% | |
Cash Ratio | 0.08 +30.50% | 0.06 +8.66% | 0.05 -31.84% | 0.08 +26.46% | |
Debt-to-Equity Ratio | 5.08 -25.22% | 6.79 -25.93% | 9.17 +134.02% | -26.96 -190.08% | |
Debt-to-Assets Ratio | 0.10 +52.91% | 0.07 -14.51% | 0.08 -24.11% | 0.10 -13.55% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow